Operating Margin of Vitro Biopharma, Inc. from 31 Oct 2013 to 31 Oct 2025

Taxonomy & unit
ratio: %
Description
The operating margin measures the profit a company makes on a dollar of sales after accounting for the direct costs involved in earning those revenues.
Summary
Vitro Biopharma, Inc. quarterly and annual Operating Margin in % history and change rate from 31 Oct 2013 to 31 Oct 2025.
  • Vitro Biopharma, Inc. Operating Margin for the quarter ending 31 Oct 2025 was -244%, a 50% increase year-over-year.
  • Vitro Biopharma, Inc. annual Operating Margin for 2025 was -244%, a 50% increase from 2024.
  • Vitro Biopharma, Inc. annual Operating Margin for 2024 was -493%, a 62% decline from 2023.
  • Vitro Biopharma, Inc. annual Operating Margin for 2023 was -305%.
Operating Margin, Quarterly (%)
Operating Margin, YoY Quarterly Change (%)
Operating Margin, Annual (%)
Operating Margin, YoY Annual Change (%)

Vitro Biopharma, Inc. Quarterly Operating Margin (%)

Period Value YoY Chg Change % Start Date End Date
Q3 2025 -244% +249% +50% 01 Aug 2025 31 Oct 2025
Q2 2025 -280% +202% +42% 01 May 2025 31 Jul 2025
Q1 2025 -344% +68% +17% 01 Feb 2025 30 Apr 2025
Q4 2024 -326% +168% +34% 01 Nov 2024 31 Jan 2025
Q3 2024 -493% -188% -62% 01 Aug 2024 31 Oct 2024
Q2 2024 -481% 01 May 2024 31 Jul 2024
Q1 2024 -412% 01 Feb 2024 30 Apr 2024
Q4 2023 -494% 01 Nov 2023 31 Jan 2024
Q3 2023 -305% 01 Aug 2023 31 Oct 2023

Vitro Biopharma, Inc. Annual Operating Margin (%)

Period Value YoY Chg Change % Start Date End Date
2025 -244% +249% +50% 01 Nov 2024 31 Oct 2025
2024 -493% -188% -62% 01 Nov 2023 31 Oct 2024
2023 -305% 01 Nov 2022 31 Oct 2023
2015 -203% -60% -42% 01 Nov 2014 31 Oct 2015
2014 -143% +517% +78% 01 Nov 2013 31 Oct 2014
2013 -659% 01 Nov 2012 31 Oct 2013
* An asterisk sign (*) next to the value indicates that the value is likely invalid.